Cf. Cuff et al., ENTERIC REOVIRUS INFECTION AS A PROBE TO STUDY IMMUNOTOXICITY OF THE GASTROINTESTINAL-TRACT, TOXICOLOGICAL SCIENCES, 42(2), 1998, pp. 99-108
The gastrointestinal (GI) tract contains a complex immune system that
defends the host against a wide range of pathogens and toxins. The GI
tract is also exposed to many environmental toxins that could adversel
y affect intestinal immunity, and few systems to study immunotoxicity
of the GI tract have been described. We demonstrate that intestinal re
ovirus infection can be used as a system to assess the effects of toxi
ns on intestinal and systemic immunity. Mice were given various doses
of cyclophosphamide (CY) for 5 days at doses ranging from 100 to 500 m
g/kg by the oral route or 200 mg/kg by the intraperitoneal route, On d
ay 3 of dosing, mice were orally infected with reovirus serotype 1, st
rain Lang. The effects of CY on viral clearance, intestinal and system
ic immune responses, and distribution of intestinal lymphocytes were a
ssessed. Mice treated with CY failed to clear the virus in a dose-depe
ndent manner, and serum anti-reovirus antibody titers were suppressed.
Virus-specific IgA in cultures of intestinal tissue from CY-treated m
ice was significantly reduced compared to controls, although total IgA
production was not affected. The virus-specific cytotoxic T-cell resp
onse in spleen was also suppressed in CY-treated animals. Cyclophospha
mide treatment reduced the number and percentage of B-cells in Peyer's
patches. Reovirus infection did not increase cellularity of Peyer's p
atches in CY-treated mice. Cyclophosphamide treatment also had little
effect on the phenotype of intestinal intraepithelial lymphocytes. The
se data demonstrate that intestinal reovirus infection is useful in st
udying exposure of the GI tract to immunotoxic agents. (C) 1998 Societ
y of Toxicology.